Viking Therapeutics Stock Probability of Future Stock Price Finishing Over 7.06

VKTX Stock  USD 82.00  1.34  1.61%   
Viking Therapeutics' implied volatility is one of the determining factors in the pricing options written on Viking Therapeutics. Implied volatility approximates the future value of Viking Therapeutics based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in Viking Therapeutics over a specific time period. For example, 2024-04-05 CALL at $82.0 is a CALL option contract on Viking Therapeutics' common stock with a strick price of 82.0 expiring on 2024-04-05. The contract was last traded on 2024-03-28 at 15:44:29 for $3.2 and, as of today, has 7 days remaining before the expiration. The option is currently trading at a bid price of $3.0, and an ask price of $3.4. The implied volatility as of the 29th of March is 69.77. View All Viking options

Closest to current price Viking long CALL Option Payoff at Expiration

Viking Therapeutics' future price is the expected price of Viking Therapeutics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Viking Therapeutics performance during a given time horizon utilizing its historical volatility. Check out Viking Therapeutics Backtesting, Viking Therapeutics Valuation, Viking Therapeutics Correlation, Viking Therapeutics Hype Analysis, Viking Therapeutics Volatility, Viking Therapeutics History as well as Viking Therapeutics Performance.
For more information on how to buy Viking Stock please use our How to Invest in Viking Therapeutics guide.
  
At this time, Viking Therapeutics' Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 5.29 in 2024, whereas Price Earnings Ratio is likely to drop (21.46) in 2024. Please specify Viking Therapeutics' target price for which you would like Viking Therapeutics odds to be computed.

Viking Therapeutics Target Price Odds to finish over 7.06

The tendency of Viking Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay above $ 7.06  in 90 days
 82.00 90 days 7.06 
about 91.7
Based on a normal probability distribution, the odds of Viking Therapeutics to stay above $ 7.06  in 90 days from now is about 91.7 (This Viking Therapeutics probability density function shows the probability of Viking Stock to fall within a particular range of prices over 90 days) . Probability of Viking Therapeutics price to stay between $ 7.06  and its current price of $82.0 at the end of the 90-day period is about 85.49 .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.05 . This entails as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Viking Therapeutics will likely underperform. In addition to that Viking Therapeutics has an alpha of 2.8043, implying that it can generate a 2.8 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
   Viking Therapeutics Price Density   
       Price  

Predictive Modules for Viking Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Viking Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Viking Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
49.2966.0582.81
Details
Intrinsic
Valuation
LowRealHigh
32.6349.3990.20
Details
11 Analysts
Consensus
LowTargetHigh
30.7633.8037.52
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.32-0.28-0.24
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Viking Therapeutics. Your research has to be compared to or analyzed against Viking Therapeutics' peers to derive any actionable benefits. When done correctly, Viking Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Viking Therapeutics.

Viking Therapeutics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Viking Therapeutics is not an exception. The market had few large corrections towards the Viking Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Viking Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Viking Therapeutics within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
2.80
β
Beta against NYSE Composite2.05
σ
Overall volatility
25.64
Ir
Information ratio 0.18

Viking Therapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Viking Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Viking Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Viking Therapeutics is way too risky over 90 days horizon
Viking Therapeutics appears to be risky and price may revert if volatility continues
Net Loss for the year was (85.89 M) with profit before overhead, payroll, taxes, and interest of 0.
Viking Therapeutics currently holds about 155.02 M in cash with (73.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.02.
Viking Therapeutics has a frail financial position based on the latest SEC disclosures
Roughly 74.0% of the company outstanding shares are owned by institutional investors
Latest headline from news.google.com: 5 Things You Need to Know If You Buy Viking Therapeutics Stock Today - Yahoo Finance

Viking Therapeutics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Viking Stock often depends not only on the future outlook of the current and potential Viking Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Viking Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding94.3 M
Cash And Short Term Investments362.1 M

Viking Therapeutics Technical Analysis

Viking Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Viking Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Viking Therapeutics. In general, you should focus on analyzing Viking Stock price patterns and their correlations with different microeconomic environments and drivers.

Viking Therapeutics Predictive Forecast Models

Viking Therapeutics' time-series forecasting models is one of many Viking Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Viking Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Viking Therapeutics

Checking the ongoing alerts about Viking Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Viking Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Viking Therapeutics is way too risky over 90 days horizon
Viking Therapeutics appears to be risky and price may revert if volatility continues
Net Loss for the year was (85.89 M) with profit before overhead, payroll, taxes, and interest of 0.
Viking Therapeutics currently holds about 155.02 M in cash with (73.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.02.
Viking Therapeutics has a frail financial position based on the latest SEC disclosures
Roughly 74.0% of the company outstanding shares are owned by institutional investors
Latest headline from news.google.com: 5 Things You Need to Know If You Buy Viking Therapeutics Stock Today - Yahoo Finance
When determining whether Viking Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Viking Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Viking Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Viking Therapeutics Stock:

Complementary Tools for Viking Stock analysis

When running Viking Therapeutics' price analysis, check to measure Viking Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viking Therapeutics is operating at the current time. Most of Viking Therapeutics' value examination focuses on studying past and present price action to predict the probability of Viking Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viking Therapeutics' price. Additionally, you may evaluate how the addition of Viking Therapeutics to your portfolios can decrease your overall portfolio volatility.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Is Viking Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Viking Therapeutics. If investors know Viking will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Viking Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.91)
Return On Assets
(0.23)
Return On Equity
(0.35)
The market value of Viking Therapeutics is measured differently than its book value, which is the value of Viking that is recorded on the company's balance sheet. Investors also form their own opinion of Viking Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Viking Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Viking Therapeutics' market value can be influenced by many factors that don't directly affect Viking Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Viking Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Viking Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Viking Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.